1. Radicava represents the first FDA-approved treatment for amyotrophic lateral sclerosis — or Lou Gehrig’s disease — in 22 years.
2. Keytruda may now be used, in combination with chemotherapy, for previously untreated patients with advanced lung cancer.
3. Bavencio may now be used to treat advanced or metastatic bladder cancer in patients whose disease still progresses after chemotherapy.
More articles on supply chain:
WHO calls for global drug price transparency
Patients barter for costly medications on Facebook
PhRMA issues new membership criteria, boots more than 20 drugmakers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
